4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000218
COFO and Secretary sold 15,558 shares at an average $29.91 ($465,286)
- COFO and Secretary acquired 15,558 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Schuth Alexander O. · COFO and Secretary
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,558 | $5.28 | $82,146 | 193,624 | D |
| 2024-11-07 | Sale : show line 2 in the form 10b5-1 | −12,333 | $29.68 | $366,043 | 181,291 | D |
| 2024-11-07 | Sale : show line 3 in the form 10b5-1 | −2,925 | $30.72 | $89,856 | 178,366 | D |
| 2024-11-07 | Sale : show line 4 in the form 10b5-1 | −300 | $31.29 | $9,387 | 178,066 | D |
| Open-market sales · 15,558 sh · avg $29.91 · $465,286 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-07 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −15,558 | 53,379 | D |
Loading xslF345X05/wk-form4_1731447884.xml…